Itinera

Itinera says:

enough

Enough dithering around.
Enough missed opportunities.
This country deserves better policies,
in a better Europe, with more thoughtful choices.

Itinera supports with insights and inspiration
societal leaders who, like us, 
dare to say “enough”.

Every day.

Read moreAbout Itinera

What keeps us awake

THE PHARMA URGENCY FOR BELGIUM AND EUROPE


Itinera calls on Belgian and European policymakers to develop a long-term innovation and growth strategy for the pharmaceutical, biotech and life sciences sector. “We have a choice between a frontrunner ambition involving strong biopharma nations such as Belgium, or a collective decline that will erode not just a high value-add sector but entire ecosystems of the knowledge economy, while increasing foreign dependencies”, says Marc De Vos, co-author and Co-CEO of Itinera. This report offers an agenda for immediate action to boost the innovation potential and investment attractiveness of Belgium. “It should be seen as a stepping-stone to a genuine industrial policy for biopharma and life sciences, transcending the political cycle.”

This call builds on a report of a roundtable with a wide range of business leaders, stakeholders and policy experts. The report identifies four areas in which, according to roundtable participants, policymakers can take targeted immediate action.

Read more

News